Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thin Basement Membrane Disease”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableLooking for participantsNCT02378805
What this trial is testing

Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

Who this might be right for
Alport SyndromeHereditary Kidney DiseasePediatric Kidney Disease+2 more
University Hospital Goettingen 800
Not applicableStudy completedNCT01465126
What this trial is testing

Enalapril in Collagen Type 4 Nephropathy

Who this might be right for
Collagen Type-4 Nephropathies
University of Sao Paulo 19
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Post-approval studies (Phase 4)Active Not RecruitingNCT06499948
What this trial is testing

Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT)

Who this might be right for
Alport SyndromeThin Basement Membrane DiseaseAlport Nephropathy
Stefan Lujinschi 34
Not applicableLooking for participantsNCT06526741
What this trial is testing

ASF Alport Patient Registry

Who this might be right for
Alport SyndromeThin Basement Membrane DiseaseHereditary Nephritis
Alport Syndrome Foundation 2,500
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13